jens juul holst glp 1 Event information Jens Juul Holst modtager Lægeforeningens

These complications could prove fatal without urgent medical attention

Even during the peak of that career, she told NBC News, she struggled to lose weight from diet and exercise

On Thursday, Eli Lilly, the maker of tirzepatide, issued a warning to the public

A Primer on the Weight Loss, Health & Longevity Benefits of GLP-1 Receptor Agonists Reading Time: 7 minutes | GLP-1 (Glucagon-like peptide-1) receptor agonists (RAs) therapies are in demand for weight loss because of the obesity epidemic, and because they work

For a detailed peptide-by-peptide account and vote explanation, see FDA Peptide Compounding Vote 2026: What the Recommendation Means for Patients